Stay updated on Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The revision label at the bottom of the page updated from v3.3.1 to v3.3.2, which is a UI/version detail and does not affect study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:09:44.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The record history now includes Revision: v3.3.1 and removes Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T12:59:17.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A government funding/status notice that previously appeared on the page has been removed; the overall history content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-17T06:26:10.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    New screenshot shows the same version history entries with only minor visual adjustments to headers and spacing; no core data or version entries were added or removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T01:08:01.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Major update: new operating-status notice and a v3.2.0 version release, replacing the prior v3.1.0.
    Difference
    10%
    Check dated 2025-10-05T09:35:08.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T03:08:58.000Z thumbnail image

Stay in the know with updates to Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Capmatinib & Spartalizumab vs Docetaxel in NSCLC Clinical Trial page.